CSL stock after-hours at EUR 112.59: plus 1.33 percent versus the prior close at Lang & Schwarz
Published on 10/07/2026 at 20:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
CSL stock was at EUR 112.59 after-hours at 8:28 p.m. CEST on October 7, 2026, up 1.33 percent versus the prior close at Lang & Schwarz. The prior close was EUR 111.11 on October 6. The euro quote was separate from the company’s primary listing in Australia and does not indicate a move on the Australian exchange.
Trading details
Lang & Schwarz showed a bid of EUR 111.52 and an ask of EUR 113.66 for CSL at the recorded time. The price was in the after-hours phase for German investors, following the 5:30 p.m. CEST Xetra close. CSL is identified as ASX:CSL in the company’s investor materials. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CEST is shown by the continuously updated real-time quote of CSL stock.
Recent company context
On October 5, 2026, CSL and Alentis Therapeutics announced an exclusive global collaboration to co-develop and co-promote lixudebart, an investigational therapy targeting claudin-1 in kidney, liver and other diseases, with CSL making an initial US$355 million payment, funding several clinical-development programs and receiving 55 percent of global profits after commercialization, according to the CSL newsroom.
